West Pharmaceutical Services, Inc.

Founded in 1923 and publicly traded under NYSE: WST, West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services and helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. The company's major products include containment solutions, prefillable systems, reconstitution and transfer systems, drug delivery systems, primary packaging, cartridge systems and components and specialty components, and it also offers contract manufacturing and analytical lab services.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support its customers by delivering over 41 billion components and devices each year. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue).

Recent Leadership News

West's Board of Directors has appointed Michel Lagarde to be President and Chief Executive Officer effective August 31, 2026, succeeding Eric M. Green, who will retire from his roles as President, CEO and Board Chair on that date. Lagarde brings expertise as an Executive Vice President and Chief Operating Officer from Thermo Fisher Scientific, served as a Managing Director at JLL Partners from 2008 to 2016, and joined the Board of Directors of Vertex Pharmaceuticals in 2023 and is serving as Chair of the Audit and Finance Committee.